Praxis Precision Medicines Inc (PRAX)
45.27
+0.06
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
45.27
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Cash from Investing (Quarterly): -91.22M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -91.22M |
| December 31, 2023 | -0.05M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 5.00M |
| March 31, 2023 | 34.00M |
| December 31, 2022 | 22.59M |
| September 30, 2022 | 47.96M |
| June 30, 2022 | 34.89M |
| March 31, 2022 | -8.55M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.17M |
| September 30, 2021 | 13.55M |
| June 30, 2021 | -24.23M |
| March 31, 2021 | -140.01M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-140.01M
Minimum
Mar 2021
47.96M
Maximum
Sep 2022
-5.641M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | -0.199M |
| Regeneron Pharmaceuticals Inc | -1.687B |
| Atossa Therapeutics Inc | -0.006M |
| ADMA Biologics Inc | -2.362M |
| Viking Therapeutics Inc | -459.79M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.86M |
| Cash from Financing (Quarterly) | 182.76M |
| Free Cash Flow | -99.15M |
| Free Cash Flow Per Share (Quarterly) | -1.50 |
| Free Cash Flow to Equity (Quarterly) | -20.86M |
| Free Cash Flow Yield | -23.82% |